FDA Inspection 918008 — Zhejiang Hisun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Hisun Pharmaceutical Co., Ltd. on March 7, 2015 in Taizhou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 7, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)